Cargando…
Are patients with inflammatory eye disease treated with systemic immunosuppressive therapy at increased risk of malignancy?
The purpose of this study is to review the literature on the risk of malignancy in patients with inflammatory eye disease (IED) treated with systemic immunosuppressive (IS) therapy. Relevant databases in transplant medicine, autoimmune diseases and literature regarding uveitis and scleritis were rev...
Autores principales: | Yates, William B, McCluskey, Peter J, Wakefield, Denis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3695808/ https://www.ncbi.nlm.nih.gov/pubmed/23724805 http://dx.doi.org/10.1186/1869-5760-3-48 |
Ejemplares similares
-
Recent Developments in HLA B27 Anterior Uveitis
por: Wakefield, Denis, et al.
Publicado: (2021) -
Ocular Toxoplasmosis in a Tertiary Referral Center in Sydney Australia—Clinical Features, Treatment, and Prognosis
por: Yates, William B., et al.
Publicado: (2019) -
Systemic immunosuppressive therapies for uveitis in developing countries
por: Agrawal, Hitesh, et al.
Publicado: (2020) -
The Role of Lumican in Ocular Disease
por: Amjadi, Shahriar, et al.
Publicado: (2013) -
Role of toll-like receptors in human iris pigment epithelial cells and their response to pathogen-associated molecular patterns
por: Mai, Kelly, et al.
Publicado: (2014)